SEC Form 4 · accession 0001225208-15-013119
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald E Morel Jr.
Officer — Chair of the Board & CEO
Period of report
May 29, 2015
Accepted (ET)
Jun 2, 2015 · 11:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 29, 2015 | S | 20,000 | $54.4858 | D | 774,187 | D | |
| Common Stock | holding | — | — | — | 2,710 | I | By Savings Plan | |
| Common Stock | holding | — | — | — | 24,670 | I | Non-Qualified Deferred Compensation Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $54.34 to $54.58, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.